Bull Notes Keep Coming For These 2 Drugmakers

Analysts see much more upside for PCRX and RARE stocks

Managing Editor
Aug 3, 2018 at 10:03 AM
facebook X logo linkedin


Two drug stocks received some bullish analyst attention this morning. Analysts believe both drugmakers Pacira Pharmaceuticals Inc (NASDAQ:PCRX) and Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) are poised to keep climbing in the near future. 

PCRX Eyeing An Extended Rally

Pacira stock is up 4.4% to trade at $44.90, after three brokerages issued price-target hikes, including to $52 from $48 at H.C. Wainwright. The drug name is fresh off an upbeat earnings report yesterday, and the continued momentum today puts the shares at their highest mark since January, putting the stock right near its year-to-date breakeven point.

A short squeeze could drive PCRX even higher. Short interest fell by 16% in the two most recent reporting periods, yet the 4.01 million shares sold short represent nearly 13% of the equity's total available float. It would take seven days for shorts to buy back their positions, at the stock's average daily trading volume. 

RARE Extends Pullback Despite Bull Note

Ultragenyx stock is down 2.6% to trade at $77.52, despite Raymond James upping its price target by $15 to $86. The biotech concern also reported smaller-than-expected quarterly loss yesterday, which prompted three additional price-target hikes as well. Today's drop has RARE stock breaching its 50-day moving average, a trendline that briefly contained a pullback from the security's annual high of $87.33 on July 17.

A short squeeze is also in play for RARE. Short interest dropped off 2% in the most recent reporting period, but the 4.98 million shares sold short still represent almost 12% of the stock's total available float, and nearly 13 days' worth of pent-up buying power, based on average trading volumes.

 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI